Advik Laboratories: All resolutions passed at 32nd AGM

MPS Pharmaa Limited (formerly Advik Laboratories Ltd) announced that all resolutions proposed at its 32nd Annual General Meeting (AGM) held on September 29, 2026, were duly passed by shareholders with the requisite majority. Key approvals included the adoption of the Audited Financial Statements for the year ended March 31, 2026, and the re-appointment of Mr. Ram Niwas Sharma as a Non-Executive Director. Shareholders also approved the re-appointment of M/s. Nemani Garg Agarwal & Co. as Statutory Auditors for a five-year term and the appointment of Ms. Anchal Goyal as an Independent Director for five years. Additionally, approval was granted for Related Party Transactions and transactions under Section 185 of the Companies Act, 2013.